- Home
- PMEC vs MODD Comparison
PMEC vs MODD Comparison
Compare PMEC & MODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PMEC | MODD |
|---|---|---|
| Founded | 1984 | 1998 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | | Industrial Specialties |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 40.0M | 33.0M |
| IPO Year | 2023 | N/A |
Fundamental Metrics
Financial Performance| Metric | PMEC | MODD |
|---|---|---|
| Price | $1.07 | $0.34 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 192.6K | ★ 466.3K |
| Earning Date | 01-01-0001 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $74,349,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 2.52 | N/A |
| 52 Week Low | $0.54 | $0.28 |
| 52 Week High | $2.44 | $1.69 |
Technical Indicators
Market Signals| Indicator | PMEC | MODD |
|---|---|---|
| Relative Strength Index (RSI) | 47.77 | 34.03 |
| Support Level | $0.98 | $0.30 |
| Resistance Level | $1.09 | $0.47 |
| Average True Range (ATR) | 0.06 | 0.05 |
| MACD | 0.04 | -0.00 |
| Stochastic Oscillator | 93.55 | 30.58 |
Price Performance
Historical ComparisonAbout PMEC Primech Holdings Ltd.
Primech Holdings Ltd is a technology-driven facilities services provider in the public and private sectors operating mainly in Singapore. The services offered by the company include Facilities services, Stewarding services, Cleaning services to offices, Cleaning services to homes, and Cleaning Supplies.
About MODD Modular Medical Inc.
Modular Medical Inc is a development stage medical device company which focuses on the design, development, and commercialization of insulin pumps using modernized technology to increase pump adoption in the diabetes marketplace. The company's products seek to serve both the type 1 and the rapidly growing, especially in terms of device adoption, type 2 diabetes markets.